使用药用植物和维生素治疗糖尿病的管理
Clement G Yedjou1, Jameka Grigsby2, Ariane Mbemi3
1Department of Biological Sciences, College of Science and Technology, Florida Agricultural and Mechanical University, 1610 S. Martin Luther King Blvd, Tallahassee, FL 32307, USA.
International journal of molecular sciences
|May 27, 2023
概括
药用植物和维生素在通过降低血糖和炎症来治疗糖尿病 (DM) 中表现有前途. 本综述探讨了它们作为这种慢性代谢疾病的低成本治疗策略的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学是指药理学,即药理学是指药理学.
背景情况:
- 糖尿病 (DM) 是一种慢性代谢疾病,其特征是高血糖,导致严重的并发症,如心血管和脏疾病.
- 尽管取得了进展,但DM的发病率和死亡率仍然很高,需要新的治疗方法.
- 使用药用植物和维生素的低成本干预措施是糖尿病患者可用的选择.
研究的目的:
- 审查有关糖尿病 (DM) 的当前研究.
- 探索使用药用植物和维生素进行DM管理的治疗策略.
- 识别有关这些天然药物的化学预防益处的知识差距.
主要方法:
- 搜索了包括PubMed Central,Medline和Google Scholar在内的科学数据库.
- 包括来自世界卫生组织国际临床试验注册平台的数据.
- 收集和分析相关的科学研究和临床试验.
主要成果:
- 药用植物中的植物化学物质,如*Allium sativum*, *Momordica charantia*, *Hibiscus sabdariffa* L. 和 *Zingiber officinale*,表现出抗低血糖的特性.
- 维生素C,D,E或它们的组合,通过降低血糖,炎症,脂质过氧化和血压来改善糖尿病患者的健康.
- 药用植物和维生素在DM治疗中的化疗和预防作用的证据有限.
结论:
- 药用植物和维生素对DM的预防和治疗具有显著的低血糖潜力.
- 需要进一步的研究,以充分阐明这些天然剂的生物医学意义和治疗应用.
- 解决知识差距可以导致更有效,更低成本的糖尿病管理策略.
相关概念视频
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
220
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
220


